Full Text View
Tabular View
No Study Results Posted
Related Studies
Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer (CA9CRM)
This study has been terminated.
( Difficult for recruiting )
Study NCT00942058   Information provided by Centre Hospitalier Universitaire de Saint Etienne

First Received on June 17, 2009.   Last Updated on January 28, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial